Free Trial

ZIVO Bioscience (NASDAQ:ZIVO) Stock Crosses Above 50-Day Moving Average - What's Next?

ZIVO Bioscience logo with Medical background

ZIVO Bioscience, Inc. (NASDAQ:ZIVO - Get Free Report)'s share price crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $16.66 and traded as high as $17.25. ZIVO Bioscience shares last traded at $17.21, with a volume of 301 shares trading hands.

ZIVO Bioscience Trading Down 1.7%

The stock's 50-day moving average is $16.66 and its 200-day moving average is $18.45. The company has a market cap of $65.62 million, a price-to-earnings ratio of -3.53 and a beta of 0.02.

About ZIVO Bioscience

(Get Free Report)

ZIVO Bioscience, Inc, a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health.

Featured Stories

Should You Invest $1,000 in ZIVO Bioscience Right Now?

Before you consider ZIVO Bioscience, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ZIVO Bioscience wasn't on the list.

While ZIVO Bioscience currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Analysts Are Watching These 4 Penny Stocks—You Should Too
Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines